Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo

Carcinogenesis

Volumn 29, Issue 9, 2008, Pages 1717-1724

  Yu, Weidong ^a,b   Sun, Xiaolin ^a   Clough, Nancy ^c   Cobos, Everardo ^a   Tao, Yunxia ^a   Dai, Zonghan ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABL INTERACTOR PROTEIN 1; ACTIN; BCR ABL PROTEIN; FIBRONECTIN; GENE PRODUCT; METALLOPROTEINASE; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE CLUSTER; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LEUKEMOGENESIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCID MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; FEMALE; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENE SILENCING; IMMUNOPRECIPITATION; LEUKEMIA; MATRIX METALLOPROTEINASE 14; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; PRECURSOR CELLS, B-LYMPHOID; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; SURVIVAL RATE; TYROSINE;

EID: 51849129875     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn098     Document Type: Article

References (53)

1. Druker,B.J. et al. (2001) Chronic myelogenous leukemia. Hematology Am Soc Hematol Educ Program, 87-112.
2. Melo,J.V. et al. (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer, 7, 441-453.
3. Hehlmann,R. et al. (2007) Chronic myeloid leukaemia. Lancet, 370, 342-350.
4. Ren,R. (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer, 5, 172-183.
5. Van Etten,R.A. (2007) Oncogenic signaling: New insights and controversies from chronic myeloid leukemia. J. Exp. Med., 204 461-465.
6. Verfaillie,C.M. et al. (1992) Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J. Clin. Invest., 90, 1232-1241.
7. Skorski,T. et al. (1998) The SH3 domain contributes to BCR/ ABL-dependent leukemogenesis in vivo: Role in adhesion, invasion, and homing. Blood, 91, 406-418.
8. McWhirter,J.R. et al. (1997) Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene, 15, 1625-1634.
9. Salgia,R. et al. (1997) BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Invest., 100, 46-57.
10. Salesse,S. et al. (2002) Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ ABL-induced defects in integrin function in CML. Oncogene, 21 8605-8611.
11. Salgia,R. et al. (1999) The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. Blood, 94, 4233-4246.
12. Salgia,R. et al. (1995) CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J. Biol. Chem., 270, 29145-29150.
13. Sattler,M. et al. (1997) Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J. Biol. Chem., 272, 14320-14326.
14. Skourides,P.A. et al. (1999) Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins. Oncogene, 18, 1165-1176.
15. Dai,Z. et al. (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev., 9, 2569-2582.
16. Shi,Y. et al. (1995) Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev., 9, 2583-2597.
17. Eden,S. et al. (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature, 418, 790-793.
18. Innocenti,M. et al. (2004) Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat. Cell Biol., 6 319-327.
19. Miyazaki,K. et al. (2000) Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochim. Biophys. Acta, 1493, 237-241.
20. Kunda,P. et al. (2003) Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr. Biol., 13, 1867-1875.
21. Steffen,A. et al. (2004) Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J., 23, 749-759.
22. Gautreau,A. et al. (2004) Purification and architecture of the ubiquitous Wave complex. Proc. Natl Acad. Sci. USA, 101, 4379-4383.
23. Biesova,Z. et al. (1997) Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene, 14, 233-241.
24. Wang,B. et al. (1997) ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. J. Biol. Chem., 272, 17542-17550.
25. Ziemnicka-Kotula,D. et al. (1998) Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J. Biol. Chem., 273, 13681-13692.
26. Scita,G. et al. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature, 401, 290-293.
27. Fan,P.D. et al. (2000) Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases. Mol. Cell. Biol., 20, 7591-7601.
28. Cowan,C.A. et al. (2001) The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature, 413, 174-179.
29. Lin,T.Y. et al. (2004) Abi enhances Abl-mediated CDC2 phosphorylation and inactivation. J. Biomed. Sci., 11, 902-910.
30. Gu,Y. et al. (2003) Induction of colonic epithelial cell apoptosis by p47-dependent oxidants. FEBS Lett., 540, 195-200.
31. Machuy,N. et al. (2007) c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles. J. Mol. Biol., 370, 620-632.
32. Tanos,B.E. et al. (2007) Abi-1 forms an epidermal growth factor-inducible complex with Cbl: Role in receptor endocytosis. Cell. Signal., 19, 1602-1609.
33. Campa,F. et al. (2006) A new interaction between Abi-1 and betaPIX involved in PDGF-activated actin cytoskeleton reorganisation. Cell Res., 16, 759-770.
34. Chi,S. et al. (2004) Pak regulates calpain-dependent degradation of E3b1. Biochem. Biophys. Res. Commun., 319, 683-689.
35. Huang,L. et al. (2002) Screen and identification of proteins interacting with ADAM19 cytoplasmic tail. Mol. Biol. Rep., 29 317-323.
36. Innocenti,M. et al. (2003) Phosphoinositide 3 -kinase activates Rac by entering in a complex with Eps8, Abil, and Sos-1. J. Cell Biol., 160, 17-23.
37. Innocenti,M. et al. (2005) Abil regulates the activity of N-WASP and WAVE in distinct actin-based processes. Nat. Cell Biol., 7 969-976.
38. Dai,Z. et al. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev., 12, 1415-1424.
39. Dai,Z. et al. (2001) Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Ab1 prevents Ab1 interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J. Biol. Chem., 276, 28954-28960.
40. Li,Y. et al. (2007) Bcr-Ab1 induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Ab1 interactor 1 pathway. J. Cell Sci., 120, 1436-1446.
41. Sun,X. et al. (2007) MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: Polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration. Leukemia.
42. Courtney,K.D. et al. (2000) Localization and phosphorylation of Ab1-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol. Cell. Neurosci., 16, 244-257.
43. Echarri,A. et al. (2004) Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave 1 levels. Mol. Cell. Biol., 24, 4979-4993.
44. Juang,J.L. et al. (1999) Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity. Oncogene, 18, 5138-5147.
45. Tani,K. et al. (2003) Ab1 interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Ab1 kinase. J. Biol. Chem., 278, 21685-21692.
46. Hu,Y. et al. (2004) Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet., 36, 453-461.
47. Innocenti,M. et al. (2002) Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J. Cell Biol., 156 125-136.
48. Leng,Y. et al. (2005) Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl Acad. Sci. USA, 102, 1098-1103.
49. Chen,W.T. et al. (1994) Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res. Treat., 31, 217-226.
50. Courtneidge,S.A. et al. (2005) The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion. Cold Spring Harb. Symp. Quant. Biol., 70, 167-171.
51. Linder,S. (2007) The matrix corroded: Podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol., 17, 107-117.
52. Zipfel,P.A. et al. (2006) Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling. Curr. Biol., 16, 35-46.
53. Dos Santos,C. et al. (2008) A critical role for Lyn in acute myeloid leukemia. Blood, 111, 2269-2279.